Bioptamers
Erika Molina is the Founder & CEO of Bioptamers. Prior to establishing Bioptamers, Erika gained experience as a Doctoral Student at the University of Bonn and Leipzig University, focusing on regenerative medicine and biopharmaceutical production. Erika also worked as a Scientific Researcher at Cell and Molecular Therapy Center and CellProtect Biotechnology, contributing to research on biopharmaceuticals and diabetes therapy. Erika holds a PhD in Biochemistry, an MSc in Biotechnology, and a Bachelor's degree in Biological Sciences.
This person is not in any offices
Bioptamers
Bioptamers works on the development and marketing of a new class of personalized therapies. Key elements of their strategy are the collaboration with universities, private companies, and hospitals to accelerate the translation of their expertise into improvements in clinical outcomes for cancer patients.